The U.S. Food and Drug Administration (FDA) has made some observations about the production process of the U.S. unit of Indian generic drugmaker Wockhardt Ltd, the company said on Tuesday.
Read more
Wockhardt says FDA inspected US unit in March quarter
Published in News
More from NewsMore posts in News »
- €500 million in private sector investments headed for Ukraine
- RBI asks banks to share information on exposure to Adani Group companies – Business Standard
- NSE puts some Adani firms under watch: What is additional surveillance mechanism (ASM)? – The Indian Express
- Hindenburg bet against India’s Adani puzzles rival U.S. short sellers – Reuters India
- Gautam Adani fails to calm investors as market wipeout hits $100 billion – CNN
